|
|
Volumn 63, Issue 2, 2013, Pages 296-305
|
|
Randomized double-blind, active-controlled phase 3 study to assess 12-month safety and efficacy of mirabegron, a β3-adrenoceptor agonist, in overactive bladder
a
|
|
Author keywords
Mirabegron; Overactive bladder; Tolterodine
|
|
Indexed keywords
MIRABEGRON;
PLACEBO;
TOLTERODINE;
ADULT;
ARTHRALGIA;
ARTICLE;
BACKACHE;
COMORBIDITY;
CONSTIPATION;
CONTROLLED STUDY;
CYSTITIS;
DEMOGRAPHY;
DIZZINESS;
DRUG INDUCED HEADACHE;
DRUG SAFETY;
DRUG TOLERABILITY;
FAINTNESS;
FEMALE;
HEART ARRHYTHMIA;
HUMAN;
HYPERTENSION;
INFLUENZA;
LIVER TOXICITY;
MAJOR CLINICAL STUDY;
MALE;
MICTURITION;
OUTCOME ASSESSMENT;
OVERACTIVE BLADDER;
PHASE 3 CLINICAL TRIAL;
PRIORITY JOURNAL;
QT PROLONGATION;
QUALITY OF LIFE;
QUESTIONNAIRE;
RANDOMIZED CONTROLLED TRIAL;
RHINOPHARYNGITIS;
SEIZURE;
SINGLE BLIND PROCEDURE;
SINUSITIS;
SYSTOLIC BLOOD PRESSURE;
TACHYCARDIA;
URINARY FREQUENCY;
URINE RETENTION;
XEROSTOMIA;
ACETANILIDES;
ADRENERGIC BETA-3 RECEPTOR AGONISTS;
AGED;
BENZHYDRYL COMPOUNDS;
CONSTIPATION;
CRESOLS;
DELAYED-ACTION PREPARATIONS;
DOUBLE-BLIND METHOD;
FEMALE;
HEADACHE;
HUMANS;
HYPERTENSION;
MALE;
MIDDLE AGED;
MUSCARINIC ANTAGONISTS;
PHENYLPROPANOLAMINE;
SINGLE-BLIND METHOD;
THIAZOLES;
TREATMENT OUTCOME;
URINARY BLADDER, OVERACTIVE;
URINARY INCONTINENCE, URGE;
URINARY RETENTION;
XEROSTOMIA;
|
|
EID: 84871920033
PISSN: 03022838
EISSN: 18737560
Source Type: Journal
DOI: 10.1016/j.eururo.2012.10.048 Document Type: Article |
|
Times cited : (304)
|
|
References (10)
|
